Every week, we comb through the full universe of US-listed equities looking for one thing: names the crowd hasn’t noticed yet that our scoring framework already rates highly. This week’s Hidden Gems edition surfaces five companies under $10 billion in market capitalisation that score 70 or above on our blended opportunity model — and every single one carries a clean ethical-trading/” style=”color:#D8AF44;text-decoration:underline” title=”Ethical Trading”>ethical clearance.
These aren’t speculative penny stocks or meme-driven lottery tickets. Each name sits between $500 million and $10 billion in market cap, trades on major exchanges, and has been evaluated across our multi-layer quantitative framework. We’re sharing the data, the reasoning, and the context — what you do with it is entirely your call.
The Scoring Snapshot
Before we dive into individual names, here’s the full comparison table. Blended Score reflects our multi-factor opportunity rating (higher is better), and Ethical Score confirms compliance with our ethical screening criteria.
| Ticker | Company | Sector | Price | Market Cap | Blended | Ethical | Tier |
|---|---|---|---|---|---|---|---|
| DLO | DLocal Limited | Technology | $11.24 | $3.3B | 87.8 | 76.9 | Platinum |
| ASM | Avino Silver & Gold Mines | Basic Materials | $5.84 | $1.2B | 87.2 | 92.7 | Platinum |
| BMA | Banco Macro S.A. | Financials | $84.94 | $4.9B | 81.0 | 100.0 | Gold |
| GLBE | Global-E Online Ltd. | Consumer Cyclical | $32.13 | $4.7B | 81.4 | 87.4 | Gold |
| ETON | Eton Pharmaceuticals | Healthcare | $29.13 | $815M | 75.9 | 92.5 | Gold |
Scores as of latest snapshot. Blended = multi-factor opportunity score. Ethical = ethical compliance rating. Tier assigned by scoring framework.
1. DLocal (DLO) — The Emerging-Market Payments Bridge
DLocal sits at the intersection of two powerful secular trends: the digitalisation of payments and the rise of emerging-market consumer spending. The company provides a single API that allows global merchants — think the likes of major streaming platforms, ride-hailing apps, and e-commerce giants — to accept and send payments across Latin America, Africa, and Asia.
What makes DLocal interesting at this price is the combination of its network effect and its valuation compression. The stock traded well above $30 at its post-IPO peak, and the pullback has created a scenario where the growth trajectory (revenue expansion across 40+ countries) is no longer priced at a premium. Our analysis scores it at 87.8 on the blended model, placing it in the Platinum tier — a designation reserved for names where multiple quantitative factors align simultaneously.
The emerging-market payments space is notoriously difficult to crack because of regulatory fragmentation, currency controls, and local banking complexity. DLocal has spent years building that infrastructure, and that moat compounds over time. Every new merchant integration makes the platform stickier.
Why it’s a gem: A Platinum-tier fintech with genuine infrastructure moat, trading at a fraction of its historical valuation while the underlying business continues to expand geographically.
2. Avino Silver & Gold Mines (ASM) — Precious Metals With a Clean Sheet
With gold holding comfortably above $2,500 and silver benefiting from both monetary demand and industrial applications (solar panels, electronics, EV components), the precious metals complex has quietly become one of the strongest-performing sectors of 2026. Avino Silver & Gold Mines is a small-cap producer that benefits directly from this environment.
At $5.84 per share with a $1.2 billion market cap, ASM is the smallest name on this week’s list — and that’s part of what makes it compelling. Small-cap miners offer leveraged exposure to commodity prices. When gold and silver rise, the margins on production expand disproportionately because extraction costs are relatively fixed. Avino operates mines in Mexico and British Columbia, giving it geographic diversification within a focused commodity play.
The ethical score of 92.7 is notably high for a mining company. Our screening framework evaluates business activities, revenue sources, and governance practices, and Avino clears comfortably. The blended score of 87.2 earns it a Platinum tier rating alongside DLO — reflecting strong alignment across our quantitative layers.
Why it’s a gem: A Platinum-rated precious metals producer with one of the highest ethical scores in the mining universe, offering leveraged exposure to the gold and silver supercycle at a sub-$6 entry point.
3. Banco Macro (BMA) — Argentina’s Banking Renaissance
This is the name on the list that requires the most context — and the most conviction. Banco Macro is one of Argentina’s largest private-sector banks, and its inclusion here reflects a broader thesis: that Argentina’s economic reform programme is creating a once-in-a-generation opportunity in its financial sector.
The headline number is the ethical score: a perfect 100.0. In our analysis, that means the company’s business activities, revenue composition, and governance structure pass every single criterion without exception. For a bank, that’s rare. It reflects Banco Macro’s focus on traditional commercial and retail banking — deposits, lending, payment services — without the problematic revenue streams that flag elsewhere in financial services.
At a blended score of 81.0, the quantitative case is strong. Argentine equities have been on a tear as the country’s fiscal reforms take hold, inflation decelerates (albeit from extraordinary levels), and foreign capital begins to return. Banco Macro sits at the heart of this story. As credit growth expands in a normalising economy, banks capture that directly through net interest income.
The risk, naturally, is Argentina itself. Policy reversals, political instability, or a stall in reform could unwind the thesis. But our analysis scores what it sees today, and what it sees is a well-run bank in a recovering economy with a perfect ethical clearance.
Why it’s a gem: A perfect ethical score, Gold tier quantitative rating, and direct exposure to one of the most compelling macro recovery stories in emerging markets right now.
4. Global-E Online (GLBE) — Cross-Border Commerce Infrastructure
If you’ve ever bought something from a foreign retailer’s website and the checkout handled currency conversion, localised pricing, duties calculation, and returns seamlessly — there’s a reasonable chance Global-E’s technology was running underneath. The company provides the infrastructure that enables brands to sell directly to international consumers without the operational nightmare of managing cross-border logistics, compliance, and payments themselves.
Global-E partners with major e-commerce platforms and brands, effectively becoming invisible plumbing for international retail. The business model is transaction-based: as cross-border e-commerce volumes grow, GLBE’s revenue grows with them. And the secular tailwind here is substantial — international e-commerce is growing faster than domestic e-commerce in virtually every major market.
At $32.13 and a $4.7 billion market cap, this is a mid-cap growth story that our analysis rates highly across multiple quantitative layers. The blended score of 81.4 and ethical clearance of 87.4 place it firmly in Gold tier territory. The company’s strategic partnerships and platform integrations create meaningful switching costs — once a brand has wired Global-E into its checkout flow, ripping it out is costly and disruptive.
Why it’s a gem: Invisible infrastructure for the fastest-growing segment of global e-commerce, with high switching costs, strong ethical clearance, and a Gold tier rating from our quantitative framework.
5. Eton Pharmaceuticals (ETON) — Specialty Pharma Under the Radar
Eton Pharmaceuticals operates in a corner of healthcare that rarely makes headlines but consistently generates value: specialty and niche pharmaceuticals. The company focuses on developing and commercialising products for conditions where existing treatments are inadequate, unavailable, or can be meaningfully improved upon. Think hospital-use injectables, rare disease treatments, and reformulations that address genuine clinical needs.
At $815 million in market cap, Eton is the smallest name on this list by capitalisation, and that’s precisely what puts it in “hidden gem” territory. The company has built a growing portfolio of approved products, and its pipeline strategy targets areas with limited competition — a deliberate approach that avoids the bruising pricing battles common in generic pharmaceuticals.
The ethical score of 92.5 is exceptional for a pharmaceutical company. Our screening framework examines revenue sources, business practices, and governance, and Eton’s focus on addressing unmet medical needs rather than controversial therapeutic areas contributes to its strong clearance. The blended score of 75.9 places it in Gold tier — the lowest on this week’s list, but still comfortably above our 70-point threshold.
The risk profile here is classic small-cap pharma: concentration risk in a limited product portfolio, regulatory dependency, and the potential for pipeline setbacks. But the company’s commercial-stage products provide revenue today, not just future promises, and that distinguishes Eton from the typical pre-revenue biotech story.
Why it’s a gem: A revenue-generating specialty pharma with one of the highest ethical scores in healthcare, focused on underserved therapeutic areas with limited competition, trading at a sub-$1 billion market cap.
What Ties These Five Together
Sector diversity is deliberate. We’ve selected across Technology, Basic Materials, Financials, Consumer Cyclical, and Healthcare specifically because hidden gems shouldn’t cluster in one corner of the market. Each of these companies operates in a different economic environment with different catalysts and different risk profiles.
What they share is quantitative alignment. Every name scores 70+ on our blended opportunity model, meaning multiple independent analytical layers — not just one metric — are pointing in the same direction. And every name carries a clean ethical clearance, which matters to a growing number of investors who want performance without compromise.
Two names earned Platinum tier (DLO and ASM), reflecting the strongest multi-factor convergence. Three sit in Gold tier (BMA, GLBE, ETON), which is still a high-conviction designation in our analysis. None of these are borderline calls.
Small-Cap Risk: What You Need to Know
Important Considerations for Sub-$10B Market Cap Names
- Liquidity risk: Smaller companies typically have lower trading volumes, which can mean wider bid-ask spreads and greater difficulty entering or exiting positions at desired prices.
- Volatility: Small-cap stocks tend to experience larger percentage moves in both directions. A 5-10% daily swing is not unusual, particularly around earnings or sector events.
- Concentration risk: Smaller companies often derive a larger share of revenue from fewer products, customers, or geographies, making them more sensitive to individual business developments.
- Information asymmetry: Analyst coverage is typically thinner for sub-$10B names, which means the market may be slower to price in both positive and negative developments.
- Country risk: Two names on this list (DLO, BMA) have significant emerging-market exposure, which introduces currency, political, and regulatory risk beyond the company’s control.
Our scoring framework identifies opportunity — it does not eliminate risk. A high blended score means the quantitative factors are aligned favourably, not that a stock can’t decline. Position sizing, portfolio diversification, and personal risk tolerance should always govern allocation decisions.
How We Found These
We screened our full universe for companies between $500 million and $10 billion in market capitalisation that score 70 or above on our blended opportunity model and carry an ethical clearance score of 50 or higher. This week, 20 names passed those filters. From that group, we selected five that offer the most compelling combination of sector diversity, score strength, and investment narrative.
This is a recurring weekly feature. The names change as scores update, new data flows in, and market conditions evolve. If you found this useful, the full ticker analysis for each name — including detailed scoring breakdowns — is available on the individual ticker pages linked above.
Disclaimer: This content is for informational and educational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell any securities. All investments carry risk, including the potential loss of principal. Small-cap stocks carry additional risks including lower liquidity and higher volatility. Past performance and quantitative scores do not guarantee future results. Always conduct your own research and consult a qualified financial adviser before making investment decisions. Scores and data reflect our latest available snapshot and are subject to change.
Deepen Your Understanding
Related articles from the Titan Protect Foundry:
